We are live on ! Find out more
StepStone Group

StepStone Group Portfolio holdings

AUM $2.16B Turnover 48.15%
1-Year Est. Return 20.11%
 

StepStone Group is a private markets firm that builds customized investment portfolios, monitors them and advises investors. Its business spans primary and secondary fund investments plus co-investments, across private equity, real estate, infrastructure, real assets and private debt. Its founders, Monte Brem and Thomas Keck, had earlier made private equity investments at Pacific Corporate Group, as president and managing director respectively. StepStone went public on the Nasdaq in September 2020. The firm serves institutional investors and sponsors worldwide.

This Fund
S&P 500
This Quarter Est. Return
+50.13%
1 Year Est. Return
-20.11%
3 Year Est. Return
+106.59%
5 Year Est. Return
+6.42%
10 Year Est. Return
+222.74%
AUM
$114M
AUM Growth
-$160M
Cap. Flow
-$182M
Cap. Flow %
-158.83%
Top 10 Hldgs %
98.29%
Holding
18
New
4
Increased
–
Reduced
1
Closed
4
Avg Time Held
2 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
2 years

Top Buys

Rank Stock Value
1
OKUR icon
OnKure Therapeutics
OKUR
+$7.45M
2
COIN icon
Coinbase
COIN
+$3.37M
3
METC icon
Ramaco Resources Class A
METC
+$43K

Top Sells

Rank Stock Value
1
DNB icon
Dun & Bradstreet
DNB
+$152M
2
RBLX icon
Roblox
RBLX
+$20.7M
3
RKLB icon
Rocket Lab
RKLB
+$18.8M
4
FRSH icon
Freshworks
FRSH
+$1.63M
5
NEUE icon
NeueHealth
NEUE
+$11.1K

Sector Composition

Rank Sector Weight
1 Financials 49.73%
2 Healthcare 23.69%
3 Technology 14.3%
4 Consumer Discretionary 10.47%
5 Miscellaneous 0.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ML icon
1
DELISTED
MoneyLion
ML
$53.6M 46.85%
622,931
– –
2021 Q3
13 quarters
PATH icon
2
UiPath
PATH
$6.98B
$16.4M 14.3%
1,286,527
– –
2021 Q3
13 quarters
TRDA icon
3
Entrada Therapeutics
TRDA
$201M
$13.2M 11.51%
761,277
– –
2021 Q4
12 quarters
DKNG icon
4
DraftKings
DKNG
$9.09B
$12M 10.47%
321,804
– –
2024 Q3
1 quarter
OKUR icon
5
OnKure Therapeutics
OKUR
$115M
$4.23M 3.7%
+491,938
New +$7.45M
2024 Q4
0 quarters
NEUE icon
6
DELISTED
NeueHealth
NEUE
$3.9M 3.41%
525,247
-2,103
-0.4% -$11.1K
2021 Q3
13 quarters
PHAT icon
7
Phathom Pharmaceuticals
PHAT
$478M
$3.43M 3%
422,085
– –
2021 Q3
13 quarters
COIN icon
8
Coinbase
COIN
$31.8B
$3.3M 2.88%
+13,281
New +$3.37M
2024 Q4
0 quarters
HLVX icon
9
DELISTED
HilleVax
HLVX
$1.71M 1.5%
826,569
– –
2022 Q2
10 quarters
VCSA icon
10
DELISTED
Vacasa
VCSA
$722K 0.63%
147,261
– –
2021 Q4
12 quarters
TNYA icon
11
Tenaya Therapeutics
TNYA
$78M
$661K 0.58%
462,163
– –
2021 Q3
13 quarters
GROV icon
12
Grove Collaborative
GROV
$40M
$529K 0.46%
380,383
– –
2022 Q2
10 quarters
METC icon
13
Ramaco Resources Class A
METC
$401M
$38.9K 0.03%
+3,875
New +$43K
2024 Q4
0 quarters
DNB icon
14
DELISTED
Dun & Bradstreet
DNB
– –
-13,219,351
Closed -$152M –
FRSH icon
15
Freshworks
FRSH
$3.52B
– –
-141,735
Closed -$1.63M –
RBLX icon
16
Roblox
RBLX
$33.6B
– –
-466,666
Closed -$20.7M –
RKLB icon
17
Rocket Lab
RKLB
$39.9B
– –
-1,936,599
Closed -$18.8M –

Similar funds

StepStone Group's Q4 2024 Portfolio in Review

As of Q4 2024, StepStone Group held 18 positions worth $114M, down 58% from $274M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

StepStone Group withdrew a net $182M in Q4 2024, closing 4 positions and reducing 1 holding. Its most notable exit was Dun & Bradstreet, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Financials at 50% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.

Against the trend, StepStone Group opened a new position in OnKure Therapeutics worth $4.23M.

  • StepStone Group's largest Q4 2024 buy was OnKure Therapeutics: 491,938 shares worth $4.23M.
  • StepStone Group's biggest Q4 2024 reduction was NeueHealth, cutting an estimated $11.1K.
  • StepStone Group fully exited Dun & Bradstreet in Q4 2024, selling an estimated $152M.
  • StepStone Group's ten largest holdings make up 98% of its $114M portfolio in Q4 2024.
  • StepStone Group opened 4 new positions and closed 4 in Q4 2024.
  • StepStone Group's portfolio value fell 58% quarter-over-quarter to $114M.

Based on StepStone Group's 13F filing for Q4 2024, filed 13 Feb 2025.